Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
dexamethason
DRUG
2 trials
Sponsors
Amsterdam UMC, location VUmc
, Peking Union Medical College Hospital
Conditions
Idiopathic Multicentric Castleman's Disease
Solid Tumors
Phase 2
BCD Regimen in Newly Diagnosed Idiopathic Multicentric Castleman's Disease (iMCD)
NCT03982771
Peking Union Medical College Hospital
Idiopathic Multicentric Castleman's Disease
Start: 2019-01-01
End: 2023-01-01
Target: 30
Updated: 2019-06-12
Phase 3
MEtoclopramide, DExamethasone or Axoli to Prevent or Delay Chemotherapy-induced Nausea and Vomiting in Moderately Emetogenic Non-AC-based Chemotherapy
Completed
NCT02135510
Amsterdam UMC, location VUmc
Solid Tumors
Start: 2013-06-30
End: 2019-03-01
Updated: 2020-03-31
Related Papers
Metoclopramide, Dexamethasone, or Palonosetron for Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting After Moderately Emetogenic Chemotherapy (MEDEA): A Randomized, Phase III, Noninferiority Trial
The Oncologist
2020-07-31
20 citations